Hypothalamic Obesity
Metabolic·MeSH: Sexual Infantilism
Prevalence
42000.0 / 100K
Incidence
2000.0 / 100K/yr
5 drugs in development·2 companies·5 clinical trials
Drug Pipeline by Phase
Phase 2(3)
Preclinical(1)
| Drug | Company |
|---|---|
| pl7737 | PALATIN TECHNOLOGIES INC (PTN) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| RM-718 | RHYTHM PHARMACEUTICALS, INC. (RYTM) |
Compare drugs
Frequently asked questions
How many drugs are in development for Hypothalamic Obesity?
BioSniper tracks 5 drugs in development for Hypothalamic Obesity across 2 companies.
How many clinical trials target Hypothalamic Obesity?
There are 5 clinical trials targeting Hypothalamic Obesity tracked by BioSniper.
What is the prevalence of Hypothalamic Obesity?
The estimated prevalence of Hypothalamic Obesity is approximately 42000.0 per 100,000 population.
Deep-dive into Hypothalamic Obesity
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis